Lipid-lowering therapy's effectiveness in reducing low-density lipoprotein (LDL) cholesterol and preventing cardiovascular disease has been well-established in primary prevention trials. However, the evidence regarding its...
Most Recent Articles
Association Between Parental Incarceration During Childhood and Cardiovascular Risk in Adulthood: Findings from a Population-Based Cohort Study
This population-based cohort study aimed to investigate the association between parental incarceration during childhood and incident cardiovascular risk in adulthood. The study utilized data from waves IV (2008-2009) and V (2016...
Triple Regression in Acute Myocardial Infarction Patients: Rates, Determinants, and Prognostic Implications
Researchers aimed to investigate the frequency, characteristics, and outcomes of patients treated with high-intensity lipid-lowering therapy, showing concomitant atheroma volume reduction, lipid content reduction, and increase in...
VISUALIZED: Long-Term Effects of Mavacamten on Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
Read further: Long-Term Effects of Mavacamten on Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
Long-Term Effects of Mavacamten on Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
A recent research paper investigated the impact of mavacamten on the requirement for septal reduction therapy (SRT) in patients with severely symptomatic obstructive hypertrophic cardiomyopathy (HCM). The study aimed to assess...